Our suggested hypothesis is that synthetic retinoids can act in a way similar to ATRA and can work together with 5-FU by different molecular pathways mainly through the action on RARs nuclear receptors to achieve their overall cytotoxicity to cancer cells. The gene discussed is RARS1; the disease is cancer.